GAA-item: personalizing the prediction of anti-therapeutic antibody response in pompe disease patients
Ended Project Grant Awarded Last action
- Award ID
- R43TR002441
- Recipient
-
Epivax Inc. UEI NLAVQM513F18
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $324,980
Award facts
- Assistance listing
- 93.350 National Center for Advancing Translational Sciences
- Completion date
- Place of performance
- Providence, RI 02909, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $133,578 | |
| Amendment | $0 | |
| Original award | $191,402 |
Quick answers
Who received award R43TR002441?
R43TR002441 was awarded to Epivax Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on May 9, 2018.
How much is award R43TR002441 worth?
$324,980 has been obligated on R43TR002441.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award